Faces Of Digital Health

VR is becoming a well-established tool in healthcare and medicine to help treat pain management, anxiety, mental wellness, and more. Thousands of studies have shown the efficacy of VR approaches for health because of the impact of the immersive experience offered by this technology. We covered VR in medicine in several episodes in the past, and I’m adding the link to those in the show notes. In this episode, Aaron Gani, CEO of BehaVR, a company providing virtual reality solutions to address pain management, anxiety, mental wellness, and social engagement, shares: the latest on reimbursement, shifts in digital therapeutics companies' business models, which might make VR solutions more widely accessible with direct-to-consumer approaches, the impact of VR on decreasing opioid use in pain management, thoughts about VR and psychedelics since both approaches leverage altered states of consciousness. Enjoy the discussion. You can also read the summary of this chat on our website; the link is in the show notes

Generative AI - a subset of AI technologies that employ advanced machine learning algorithms to generate content, solutions, or outcomes that weren't explicitly programmed into the algorithms has many potential applications in healthcare. But at the moment, the digital health space is filled with noise. This discussion was recorded at HLTH 2023 in Las Vegas. Justin Norden - Partner at GSR Ventures talks about: his observes from the investor’s perspective, what he thinks about the discussions on open-sourced vs. closed AI development, why everyone should incorporate generative AI in healthcare and more. Newsletter summary of generative AI in healthcare: https://fodh.substack.com/p/generative-ai-in-healthcare Interview with Justin Norded - July 2023: https://www.facesofdigitalhealth.com/blog/investors-bet-on-in-generative-ai-in-healthcare https://www.facesofdigitalhealth.com/

Alex Merwin is Head of Growth, Healthcare & Life Sciences Startups at Amazon Web Services (AWS). In this episode, he presents the AWS Health Innovation Podcast, which showcases startups that are advancing healthcare & life science by leveraging cloud computing technology. In this episode, Alex Merwin and Tjasa Zajc, Host of Faces of Digital Health, discuss: podcasting, how AWS supports startups, what trends is Alex observing in the health innovation space, key findings from the recent Faces of Digital Health series about entrepreneurship and healthcare in Africa. ... and more.  More about AWS Health Innovation Podcast: https://healthpodcastnetwork.com/show/aws-health-innovation-podcast/  Get in touch with AWS: https://aws.amazon.com/contact-us/?trk=d7b08691-7f65-4c28-8b4e-13f1db4e310c&sc_channel=el Connect with Alex: https://www.linkedin.com/in/alexmerwin/ Newsletter: https://fodh.substack.com/

Scarsity of resources can be difficult to image: it encompasses the adaptation of clinical guidelines, palliative care instead of treatment, and clinicians accepting that they can’t help everyone, but need to choose who to save and who to palliate. Khalida Soki is a consultant physician and kidney specialist working in Nairobi. She moved back to Kenya in 2018. She participated in over 20 kidney transplants in Nairobi, successfully run a large hemodialysis unit, grown a clinic for kidney disease and helped write the COVID19 guidelines for the Ministry of Health in Kenya. She is also the organizing secretary for the young nephrologists committee at the African association of Nephrology and an honorary lecturer for the East African Kidney Institute. In this discussion, she explains: how did her transition from NHS to Kenya look like, how do clinicians operate on a daily basis with lack of resources, how they innovate because they have to, how is technology helping educate patients and improve access thro

Kenya has a lot of talent and opportunities for innovation. Access to care is not a problem because plenty of community nurses are present nationwide. However, they have a limited problem and mostly focus on main infectious diseases, leaving serious conditions undiagnosed, says Emilian Popa, Founder and CEO of Ilara Health. Ilara health equips a network of small healthcare providers with lifesaving and essential diagnostic tools to improve the quality of medical care in Sub-Saharan Africa. In this episode, Emilian Popa talks about:  why health insurance is hard to scale in Africa, where people are concerned with daily costs and survival,  investments and how local VCs mostly invest in sectors like real estate and investments for health tech are supported by foreign investors,  why Ilara Health is expanding on the Kenyan market but not in Tanzania, South Africa, Nigeria or Egypt.  Transcript: https://www.facesofdigitalhealth.com/blog/kenya-ilara-health-diagnostics-africa Website: facesofdigitalhealth.com

One of the biggest challenges for healthcare startups in Nigeria is access to market. “In Nigeria, healthcare is fragmented, making it difficult to find distribution channels. We have to be creative and may need to look outside healthcare for distribution channels.” , says Jennie Nwokoye is the founder and CEO of Clafiya - a digital primary healthcare service that connects individuals and businesses to health practitioners to provide convenient, quality, and affordable, on-demand primary care from their mobile phones. In this discussion, Jennie explains:  What are the healthcare challenges in Nigeria, How do startups do business in Nigeria and why is it difficult to scale, How do startups work with local and international investors and more Transcript: https://www.facesofdigitalhealth.com/blog/primary-care-nigeria-clafiya Newsletter: https://fodh.substack.com/

One of the speakers at the Nextmed Health Conference 2023 said: “In the past, people didn’t age; they just died.” This is still a daily reality in many low-income countries, which face a lack of workforce, poor healthcare system structure, and lack of resources. In this episode, we will learn about Nigeria. Nigeria has 220 million people which is roughly ⅔ of the population of the US. While many healthcare-related resources are scarce, the Internet is available and so is the fierce ambition of local entrepreneurs. These use digital tools to bring healthcare information and care closer to patients or to upskill the workforce. So what does care in Nigeria look like? What challenges do startups face? Where do they get investments?  Hear from: Charles Umeh, Chief Medical Officer of CribMD, Ossai Ifeanyi CEO of CribMD, Jennie Nwokoye, CEO of Clafiya and Christian Chidoziem, Pharmacy Student and Entrepreneur. Newsletter: https://fodh.substack.com/ https://www.facesofdigitalhealth.com/

Africa is a huge continent with 1.2 billion people and a diverse set of countries. Healthcare systems are generally poor, with workforce and supply chain struggles, and infrastructure challenges such as power outages. In this episode you will hear about how drones are used in Malawi for healthcare delivery. Herbert Weirather is the CEO of Jedsy - a technology company based in Switzerland with the ultimate aim of designing and developing high-end multipurpose drones. Jedsy is present in Switzerland, Malawi, India and Brazil. In this discussion, Herbert explained: What challenges are present in the medical supply chain in Africa, Which stakeholders does the company work with, what’s their business model, and why there is no such thing as competition in the medical supply drone delivery space, because healthcare needs all the help it can get.  Newsletter: https://fodh.substack.com/ https://www.facesofdigitalhealth.com/ Jedsy: https://www.youtube.com/watch?v=gGaXHdjoQ-Q https://jedsy.com/

In June 2021, France announced a €7.5 billion Health Innovation Plan, as part of a broader financial investment to boost the French industry.  This funding goes beyond digital health, it’s aimed at supporting biotech development, startups, medtech, and more. In 2021, The eHealth Acceleration Strategy was launched, a large part of which includes upskilling and training new and existing healthcare experts, and medical and social workers in digital health. In today’s discussion you will hear from Louisa Stüwe is the project director of the Ministerial eHealth delegation at the French Ministry of Health. We discussed how the French strategy was designed, who was involved, and what has been realized to date. She also explains the process for reimbursement of digital therapeutics software medical devices and telemonitoring, how France supports the secondary use of medical data, and more.  Newsletter: https://fodh.substack.com/ https://www.facesofdigitalhealth.com/ Additional resources: French core information plat

The first efforts to establish ePrescribing in the US started in 2001. However, by 2014 only 4% of clinicians had adopted it. Electronic prescribing became legal in all 50 states by 2007. Eight years later, electronic prescribing of controlled substances and prior authorization were well established on the singular ePrescribing network. In 2022, a new player entered the market, founded by FDB - a global provider of clinical decision support tools and resources for medication. FDB Vela sets itself apart with newer technology and additional features. They are also working on building a veterinarian ePrescribing network. In today’s discussion with Lathe Bigler - Vice President of Clinical Network Services at FDB (First Databank) and General Manager of FDB Vela™, you will hear more about what ePrescribing entails under the new network. Additionally, you will learn about FDB's plans to enhance medication information for patients, improve accessibility to pharmacogenomics insights, and more. Newsletter: https://fod

A systemic approach to care for non-communicable diseases like hypertension and diabetes is Africa is in its early stages, with the biggest challenge for patients being the price of medications, says Anne Stake, Chief Strategy and Product Officer at Medtronic Labs.  Medtronic Labs is a nonprofit organization that works with governments and local communities in across Africa to create local ecosystems for the management of hypertension and diabetes. In this episode, Anne Stake explains: how does Medtronic Labs work, why are they present in Africa, how to run successful non-communicable diseases programs in Africa, why regulation isn't as loose in less developed markets than the West might think, ...and more! This is a rerun of an episode first published in July 2022. www.facesofdigitalhealth.com Excerpt and full episode with Anne Stake: https://www.facesofdigitalhealth.com/blog/medtronic-labs-africa?rq=medtronic Herve Mwamba - South Africa & Africa More Broady: What’s The State of Medical Device Re

Drug development is undeniably expensive. For years, the pharmaceutical industry cited an estimate of 3 billion US dollars. However, a recent study published in 2020 discovered that the median cost actually falls between 985 million and 1.3 billion US dollars. Even within this range, it remains a substantial amount. The high cost primarily stems from the significant failure rate of new potential medications that never progress beyond clinical trials. Computational biology and AI have already assumed significant roles in drug development. The aspiration is for them to expedite the creation of new, more precise, and tailored medications. Today, we will delve into biotech and explore how technology aids in predicting a specific patient's response to a particular drug. In a conversation with Rafael Rosengarten, the CEO of Genialis - a company using machine learning and high-throughput omics data to capture underlying disease biology and predict how patients will likely respond to targeted therapies, we explored t

Chronic diseases are the result of a combination of genetic, physiological, environmental and behavioral factors. They require long-term management and often behavioral changes. Achieving long-lasting effects can be extremely difficult, and digital health solutions have since the beginning been seen as an important factor in assuring success, by providing patients with continuous monitoring and feedback. Omada Health is a US digital behavioral medicine company that uses digital tools and personalized support to help individuals living with prediabetes, diabetes, hypertension, and musculoskeletal issues. It’s been present on the market for over a decade, so in this discussion, you will hear the CEO Sean Duffy talk about what exactly does Omada do differently compared to traditional chronic care management providers, we discussed approaches to providing sustainable long-term chronic care management, and touched the topic of the sharp rise in popularity of GLP-1 drugs, we’ve seen in the last year. GLP-1 agonists

The field of generative AI companies is evolving fast and many companies, that have been exploring the field for years, are gaining in visibility. However, new companies are popping up as well. One of them is Hippocratic AI, founded in 2023. Hippocratic AI building a safety-focused large language model (LLM) for the healthcare industry. The company raised 50 million US dollars this year. In this episode, Munjal Shah, CEO and Founder of Hippocratic AI talked about what exactly does the company mean by positioning itself as a safety-based LLM, what convinced investors, how are they building the team, and why there are a lot of inefficiencies to be solved before we use generative AI for diagnosis. This episode will give you a basic understanding of:  how are large language models built,  what’s the difference between horizontally and vertically build models,  where LLMs could replace (yes, “replace” as in cater to the staffing needs in healthcare) the healthcare workforce  https://www.facesofdigitalhealth.c

Generative AI is definitely the word we will remember 2023 by. Knowing that administrative burden is among the key reason for physician burnout, the idea that AI could tackle this challenge, became a little bit more tangible with the raised awareness and public understanding of generative AI. But where are we exactly, and how is generative AI utilized for clinical use cases, administration, patient care and in biotech?  GSR Ventures and Maven Ventures are two health technology-focused VC firms that analyzed 145 startups across healthcare delivery and life sciences with generative AI solutions. They highlighted their innovations, challenges, and market potential. Collectively, the startups have earned more than $20 billion in funding and have 47,000 employees. I had the pleasure to chat with Partner at GSR Ventures Justin Norden about the report and details such as: why has biotech raised the most so far, why not are startups working on the administrative issues, how do investors look at liability issues with

Nurses play a key role in patient care, but their contribution to patient outcomes is often undervalued and underappreciated. It took a pandemic to create a major shift in their job opportunities and power to negotiate. Many nurses left the profession entirely, others switched to better-paid travel or agency jobs. The pandemic is settling down so the question debated in today’s episode, is what is the position the nurses are in today? You will hear from: Rebecca Love, Thought Leader on Nurse Innovation & Entrepreneurship, experienced nurse executive and entrepreneur, and Chief Clinical Officer of IntelyCare, Alice Benjamin, nurse, author, and health advocate is affectionately known as America's favorite nurse. Rebecca and Alice talked about the position of nurses, healthcare technologies that are not designed to make the work of nurses easier, recent criminal cases against nurses in the US, and what needs to change so that being a nurse will be an attractive job opportunity. Let’s dive in, and if you will

Healthcare is one of the rare industries, in which often times, by requesting a service, the work hardly begins for the patient. Especially in complex cases, care is rarely seamless: test are done, drugs are presribed and if all goes well the problem is resolved. But oftentimes months can pass before the right drug and dose is found. Antidepressants are a good example. They are still often prescribed on a trial and error basis, with changes made if the initial regimen proves ineffective.  But what if there was a better way for prescribing? This is where pharmacogenomic testing comes into play. By analyzing genetic variations that influence drug metabolism, efficacy, and potential adverse reactions, pharmacogenomics tests provide valuable insights for personalized treatment decisions. However, despite its potential, implementing pharmacogenomics testing is more complex than it may seem. In this discussion, you will hear from Adrijana Kekic, Pharmacogenomics Clinical Specialist at the Mayo Clinic. We discusse

Telemedicine is becoming an archaic term in 2023. It is also too broad. We now have at-home hospitals, virtual wards, remote monitoring, and more. Video consultations and online patient portals saw a spike during the pandemic. While many encounters have returned to the in-person setting, a lot of development is happening in workforce optimization. This aims to reduce the burden on hospital infrastructure and improve patient outcomes by bringing clinical staff back into patients' homes, provided they have the necessary conditions, equipment, and support for at-home care. In this episode, you will hear from Svein Willassen, Co-Founder and CEO of Confrere, the leading telehealth company in Scandinavia (acquired by Daily.co in 2022). Svein and I discussed the changing landscape of telemedicine provision, expectations from generative AI, how software providers can sell to hospitals in Nordic countries, and more. www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/

Mexico has 126 million people which is a bit more than half as much as Brazil in South America, or three times as much as Argentina, which we discussed in one of our previous episodes as well.  Mexico has a predominantly public healthcare system, with workforce shortages - only 2.4 doctors per 1000 people, which is heavily below the OECD average. For comparison, the number of doctors per 1000 people in the US is 2.6, but Denmark or Sweden on the other hand, have 4.3 doctors per 1000 people.  Diagnostikare is a healthcare provider which works with employers to provide primary care, preventative care, and mental health services through a digital platform. It is currently used by over 200.000 people in Mexico. In this episode, Rafael Lopez, CEO of Diagnostikare shared his insights in the digital patient experience in Mexico, what is the infrastructure like on the national level, how much room for digital innovation the country has, and more.  Other episodes about LATAM: Healthcare Digitalization in South Americ

In the last few episodes, you’ve been able to hear two episodes about digital health in South America. We talked about Peru with Jhonathan Bringas, MD and innovator, CEO of Lapsi Health, we dove into Argentina with Santiago Troncar, CEO and Founder or FutureDocs Latin America, and in this episode, we are looking into Chile and cancer Care in Latin America, with Luis Santiago, CEO of Pegasi. Luis was a guest on the podcast already 2 years ago, and I added the link to that episode in the show notes. PEGASI is a healthcare IT company that pivoted from EMR provision to cancer care with their oncology information system that aims to improve the time it takes to diagnose and treat cancer patients in developing countries.  Luis talked about oncology management in South America, changes in healthcare digitalization in South America after the pandemic. Other episodes: Healthcare Digitalization in South America Ep. 1: How digital is Peru? (Jhonatan Bringas) https://www.facesofdigitalhealth.com/blog/jhonatan-bringas-d